US OptionsDetailed Quotes
RIGL250117P16000
- 0.87
- 0.000.00%
15min DelayTrading Dec 16 09:38 ET
0.00High0.00Low
0.00Open0.87Pre Close0 Volume3 Open Interest16.00Strike Price0.00Turnover78.95%IV8.69%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier25DDays to Expiry0.87Extrinsic Value100Contract SizeAmericanOptions Type-0.3854Delta0.1114Gamma15.78Leverage Ratio-0.0256Theta-0.0047Rho-6.08Eff Leverage0.0167Vega
Rigel Pharmaceuticals Stock Discussion
whoa! some Dip
Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk MDS
Rigel Pharmaceuticals (Nasdaq: RIGL) announced that the FDA has granted Fast Track designation to R289 for treating patients with previously-treated transfusion dependent lower-risk myelodysplastic syndrome (LR-MDS). R289, a dual inhibitor of IRAK1 and IRAK4, is currently being evaluated in a Phase 1b study. The Fast Track designation may provide benefits including more freque...
Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk Mds
Let's break 30.+
27.+
Let's Get 30.+
No comment yet